These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12237315)

  • 1. U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells.
    Hotokezaka H; Sakai E; Kanaoka K; Saito K; Matsuo K; Kitaura H; Yoshida N; Nakayama K
    J Biol Chem; 2002 Dec; 277(49):47366-72. PubMed ID: 12237315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation.
    Lee SE; Woo KM; Kim SY; Kim HM; Kwack K; Lee ZH; Kim HH
    Bone; 2002 Jan; 30(1):71-7. PubMed ID: 11792567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL).
    Matsumoto M; Sudo T; Saito T; Osada H; Tsujimoto M
    J Biol Chem; 2000 Oct; 275(40):31155-61. PubMed ID: 10859303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor.
    Matsumoto M; Sudo T; Maruyama M; Osada H; Tsujimoto M
    FEBS Lett; 2000 Dec; 486(1):23-8. PubMed ID: 11108836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoprotegerin induces podosome disassembly in osteoclasts through calcium, ERK, and p38 MAPK signaling pathways.
    Zhao H; Liu X; Zou H; Dai N; Yao L; Gao Q; Liu W; Gu J; Yuan Y; Bian J; Liu Z
    Cytokine; 2015 Feb; 71(2):199-206. PubMed ID: 25461399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of sustained ERK activity with integrin beta3 induction during receptor activator of nuclear factor kappaB ligand (RANKL)-directed osteoclast differentiation.
    Kim HH; Chung WJ; Lee SW; Chung PJ; You JW; Kwon HJ; Tanaka S; Lee ZH
    Exp Cell Res; 2003 Oct; 289(2):368-77. PubMed ID: 14499638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines.
    Miranda MB; McGuire TF; Johnson DE
    Leukemia; 2002 Apr; 16(4):683-92. PubMed ID: 11960350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway.
    Fukazawa H; Noguchi K; Murakami Y; Uehara Y
    Mol Cancer Ther; 2002 Mar; 1(5):303-9. PubMed ID: 12489846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function.
    Li X; Udagawa N; Itoh K; Suda K; Murase Y; Nishihara T; Suda T; Takahashi N
    Endocrinology; 2002 Aug; 143(8):3105-13. PubMed ID: 12130576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-related apoptosis-inducing ligand (TRAIL) blocks osteoclastic differentiation induced by RANKL plus M-CSF.
    Zauli G; Rimondi E; Nicolin V; Melloni E; Celeghini C; Secchiero P
    Blood; 2004 Oct; 104(7):2044-50. PubMed ID: 15213096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mitogen-activated protein kinase extracellular signal-regulated kinase 1/2 pathway is involved in formyl-methionyl-leucyl-phenylalanine-induced p47phox phosphorylation in human neutrophils.
    Dewas C; Fay M; Gougerot-Pocidalo MA; El-Benna J
    J Immunol; 2000 Nov; 165(9):5238-44. PubMed ID: 11046057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms involved in enhancement of osteoclast formation and function by low molecular weight hyaluronic acid.
    Ariyoshi W; Takahashi T; Kanno T; Ichimiya H; Takano H; Koseki T; Nishihara T
    J Biol Chem; 2005 May; 280(19):18967-72. PubMed ID: 15757905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori heat-shock protein 60 induces interleukin-8 via a Toll-like receptor (TLR)2 and mitogen-activated protein (MAP) kinase pathway in human monocytes.
    Zhao Y; Yokota K; Ayada K; Yamamoto Y; Okada T; Shen L; Oguma K
    J Med Microbiol; 2007 Feb; 56(Pt 2):154-164. PubMed ID: 17244794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factor-dependent activation of the MAPK pathway in human pancreatic cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis.
    Lee KH; Hyun MS; Kim JR
    Clin Exp Metastasis; 2003; 20(6):499-505. PubMed ID: 14598883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression.
    Karsdal MA; Hjorth P; Henriksen K; Kirkegaard T; Nielsen KL; Lou H; Delaissé JM; Foged NT
    J Biol Chem; 2003 Nov; 278(45):44975-87. PubMed ID: 12933809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEK activity regulates negative selection of immature CD4+CD8+ thymocytes.
    Bommhardt U; Scheuring Y; Bickel C; Zamoyska R; Hünig T
    J Immunol; 2000 Mar; 164(5):2326-37. PubMed ID: 10679067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of raf-1 by kinase suppressor of ras is inhibited by "MEK-specific" inhibitors PD 098059 and U0126 in differentiating HL60 cells.
    Wang X; Studzinski GP
    Exp Cell Res; 2001 Aug; 268(2):294-300. PubMed ID: 11478855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
    Zhang Z; Jimi E; Bothwell AL
    J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
    Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
    J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.